- Home
- XPOF vs NMRA Comparison
XPOF vs NMRA Comparison
Compare XPOF & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPOF | NMRA |
|---|---|---|
| Founded | 2017 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.4M | 311.3M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | XPOF | NMRA |
|---|---|---|
| Price | $6.82 | $1.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $8.13 | $7.50 |
| AVG Volume (30 Days) | 570.9K | ★ 3.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.24 | 5.23 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,092,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.83 | $0.83 |
| 52 Week High | $11.14 | $3.65 |
Technical Indicators
Market Signals| Indicator | XPOF | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 47.64 |
| Support Level | $6.46 | $1.50 |
| Resistance Level | $7.11 | $2.00 |
| Average True Range (ATR) | 0.29 | 0.13 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 44.96 | 34.25 |
Price Performance
Historical ComparisonAbout XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.